Picture of BioArctic AB logo

BIOA B BioArctic AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Brief: BioArctic Says Eisai Projects Leqembi Revenue To Total JPY 56.5 Billion For FY 2024

May 14 (Reuters) - BioArctic AB  BIOAb.ST :
    * EISAI PROJECTS LEQEMBI® REVENUE TO TOTAL JPY 56.5 BILLION
FOR
FISCAL YEAR 2024 (APRIL 2024 - MARCH 2025)
    * BIOARCTIC AB  - WOULD GENERATE APPROXIMATELY SEK 360 M IN
NET
ROYALTY TO BIOARCTIC.
    * BIOARCTIC -EISAI'S FY2023 (APRIL 2023 THROUGH MARCH 2024),
LEQEMBI SALES REACHED JPY 4.3 BILLION, RESULTING IN SEK 28.2 M
IN NET ROYALTY TO BIOARCTIC

Source text for Eikon:  ID:nWkr1R3KjT 
Further company coverage:  BIOAb.ST 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on BioArctic AB

See all news